South San Francisco, CA, United States of America

Pia Challita-Eid

This inventor holds 1 USPTO granted patent. Top assignee: Cytomx Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pia Challita-Eid. Retrieved from https://idiyas.com/inventor/pia-challita-eid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pia Challita-Eid: Innovator in Polypeptide Research

Introduction

Pia Challita-Eid is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that have specific binding properties.

Latest Patents

Pia holds a patent for "Single-and Multi-Chain Polypeptides That Bind Specifically to CD3 Epsilon." This innovative work showcases her expertise in creating polypeptides that can potentially enhance therapeutic applications.

Career Highlights

Pia is currently employed at CytomX Therapeutics, Inc., where she continues to push the boundaries of scientific research. Her work is instrumental in advancing the understanding of polypeptide interactions and their implications in medicine.

Collaborations

Throughout her career, Pia has collaborated with notable colleagues, including Christopher Kemball and Rene Hubert. These partnerships have fostered a dynamic research environment that encourages innovation and discovery.

Conclusion

Pia Challita-Eid is a trailblazer in the field of biotechnology, with a focus on polypeptide research. Her contributions and collaborations are paving the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…